US Broker Ratings

Celldex Therapeutics (CLDX) Investor Outlook: Exploring an 82% Potential Upside in the Biotech Arena

Celldex Therapeutics, Inc. (NASDAQ: CLDX), a prominent player in the biotechnology sector, has captured the attention of investors with its innovative approach to treating severe inflammatory and autoimmune diseases. Based..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: A Promising 36.97% Upside in the Biotech Sector

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is capturing the attention of investors with a compelling potential upside of 36.97%, making it a noteworthy consideration in the biotechnology sector. With a current..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Exploring a 60% Potential Upside

For investors keen on the healthcare sector, Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) presents an intriguing opportunity. As a key player in the medical care facilities industry, Aveanna is making..

NeoGenomics, Inc. (NEO) Stock Analysis: Exploring a Potential 79.76% Upside for This Healthcare Challenger

NeoGenomics, Inc. (NASDAQ: NEO), a prominent player in the diagnostics and research industry, is making waves in the investment community with its recent market performance. With a market capitalization of..

Apellis Pharmaceuticals, Inc. (APLS) Investor Outlook: Exploring a 78% Potential Upside

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS), a key player in the biotechnology sector, offers intriguing opportunities for investors seeking exposure to innovative healthcare solutions. With a market capitalization of $2.41 billion,..

Haemonetics Corporation (HAE) Stock Report: Exploring a 46.57% Potential Upside Amidst a Challenging Year

Haemonetics Corporation (NYSE: HAE), a leading player in the healthcare sector specializing in medical devices, presents an intriguing yet complex investment opportunity. Based in Boston, Massachusetts, the company is renowned..

Alphatec Holdings (ATEC) Stock Analysis: Exploring a 92.92% Potential Upside in the Medical Devices Sector

Alphatec Holdings, Inc. (NYSE: ATEC), a key player in the medical devices industry, has captured the attention of investors with a remarkable potential upside of 92.92%. Specializing in innovative spinal..

MiMedx Group, Inc (MDXG) Stock Analysis: Biotechnology Innovator with 119.20% Potential Upside

Investors seeking opportunities in the healthcare sector may want to turn their attention to MiMedx Group, Inc (MDXG), a promising player in the biotechnology industry. With a market capitalization of..

Denali Therapeutics (DNLI) Stock Analysis: Assessing a 60% Upside Potential in Neurodegenerative Therapies

Denali Therapeutics Inc. (NASDAQ: DNLI) is making waves in the biotechnology sector with its innovative approach to tackling neurodegenerative and lysosomal storage diseases. With a market capitalization of $3.26 billion,..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Unveiling a Potential 289% Upside in the Biotech Sector

Investors with a keen interest in the biotechnology sector may find Janux Therapeutics, Inc. (NASDAQ: JANX) an intriguing prospect, thanks to its promising pipeline and potential upside. With a market..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Exploring a 19% Upside Potential

Healthcare Services Group, Inc. (NASDAQ: HCSG), a prominent player in the medical care facilities sector, presents a compelling opportunity for investors seeking exposure within the healthcare industry. With a market..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a Potential 74.9% Upside for Savvy Investors

Perrigo Company plc (NYSE: PRGO) presents an intriguing opportunity for investors seeking to capitalize on potential upside in the healthcare sector. Known for its robust portfolio of over-the-counter health and..

BioLife Solutions, Inc. (BLFS) Investor Outlook: Aiming for 69.81% Upside Potential

BioLife Solutions, Inc. (NASDAQ: BLFS), a notable player in the healthcare sector specializing in medical instruments and supplies, is capturing investor attention with its impressive growth metrics and the potential..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Healthcare Giant with 36.64% Upside Potential

Brookdale Senior Living Inc. (NYSE: BKD), a major player in the healthcare sector, operates within the medical care facilities industry and focuses on the senior living community market in the..

Indivior Pharmaceuticals, Inc. (INDV) Stock Analysis: A 51% Potential Upside Awaits Investors

Investors seeking opportunities in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, should not overlook Indivior Pharmaceuticals, Inc. (NASDAQ: INDV). With a market capitalization of $3.87..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: A Promising 52.68% Upside Potential Awaits Investors

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a promising player in the biotechnology sector focusing on dermatological treatments, presents a compelling case for investors seeking growth opportunities. With an impressive market capitalization..

Ocular Therapeutix, Inc. (OCUL): Analyst Ratings Suggest 203% Upside Potential in Biotech Sector

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a player in the biotechnology sector, has been making waves with its innovative approach to treating retinal diseases and other eye conditions. Headquartered in Bedford,..

Amphastar Pharmaceuticals (AMPH) Stock Analysis: A Potential 49% Upside in Healthcare

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a key player in the drug manufacturing sector, presents an intriguing opportunity for investors looking to capitalize on the healthcare industry’s growth. With a market..

Surgery Partners, Inc. (SGRY) Stock Analysis: Exploring a 56% Upside Potential Amid Market Challenges

Surgery Partners, Inc. (NASDAQ: SGRY), a key player in the healthcare sector specializing in medical care facilities, presents a complex yet intriguing case for individual investors. With a market capitalization..

AdaptHealth Corp. (AHCO) Stock Analysis: Is a 23% Upside Within Reach?

AdaptHealth Corp. (NASDAQ: AHCO), a key player in the healthcare sector specializing in medical devices, is drawing investor attention with a promising potential upside of 23.56%. With a market capitalization..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds